Yoon-Myung Kim

Yoon-Myung Kim

Auto-generated profile, based on publicly available information

Yoon-Myung Kim

University College, Yonsei University, Incheon 21983, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2019 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
EKEungu Kang
Eungu Kang
YKYoon-Myung Kim
Yoon-Myung Kim
GSGo Hun Seo
Go Hun Seo
AOArum Oh
Arum Oh
HYHee Mang Yoon
Hee Mang Yoon
BLBeom Hee Lee
Beom Hee Lee

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SWSarah Woo
Sarah Woo
HYHeonil Yang
Heonil Yang
YKYoonMyung Kim
YoonMyung Kim
HLHyunjung Lim
Hyunjung Lim
HSHong Ji Song
Hong Ji Song
KPKyung Hee Park
Kyung Hee Park
Woo S, et al. J Korean Med Sci. 2022 Mar;37(12):e103. https://doi.org/10.3346/jkms.2022.37.e103

13 December 2017 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
YKYoon-Myung Kim
Yoon-Myung Kim
GSGo Hun Seo
Go Hun Seo
EJEuiseok Jung
Euiseok Jung
JJJa-Hyun Jang
Ja-Hyun Jang
SKSook Za Kim
Sook Za Kim
BLBeom Hee Lee
Beom Hee Lee

31 May 2023 in Neonatal Medicine
Verified
Journal Article
Open access
PDF file
YPYoung Mi Park
Young Mi Park
YKYoon-Myung Kim
Yoon-Myung Kim
SOSeong Hee Oh
Seong Hee Oh
HJHyun-Seung Jin
Hyun-Seung Jin
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) is a rare genetic disorder characterized by megalencephaly, polymicrogyria, body overgrowth, and cutaneous capillary malformations. It has been reported recently that MCAP is related to a somatic mosaic mutation in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene. We report a case of hemimegalencephaly with polymicrogyria and cutaneous capillary malformations diagnosed by genetic evaluation of MCAP in the neonatal period. The PIK3CA mutation [c.1635G>T (p. Glu545Asp)] was determined by Sanger sequencing. The patient was treated with a ventriculoperitoneal shunt for progressive hydrocephalus. Because of the dynamic, progressive clinical manifestations and tumor-prone traits of MCAP, early diagnosis is important. Moreover, since the phosphoinositide 3-kinase (PI3K)-specific inhibitor, a targeted therapy for the PI3K/AKT/mTOR signaling pathway is emerging as a new therapy, early genetic diagnosis is becoming increasingly important.

1 January 2025 in Clinical Nutrition Research
Verified
Journal Article
Open access
PDF file
HLHangsook Lee
Hangsook Lee
JKJieun Kim
Jieun Kim
NKNayoung Kim
Nayoung Kim
HPHyung Gyu Park
Hyung Gyu Park
YKYoon Myung Kim
Yoon Myung Kim
HLHyunjung Lim
Hyunjung Lim
Lee H, et al. Clin Nutr Res. 2025 Jul;14(3):164-173. https://doi.org/10.7762/cnr.2025.14.3.164

1 January 2024 in Clinical Nutrition Research
Verified
Journal Article
Open access
PDF file
YKYerin Kim
Yerin Kim
GSGyeong Seob Shin
Gyeong Seob Shin
JPJungwon Park
Jungwon Park
MKMinji Kang
Minji Kang
KSKumhee Son
Kumhee Son
HLHyunjung Lim
Hyunjung Lim
Kim Y, et al. Clin Nutr Res. 2024 Jan;13(1):8-21. https://doi.org/10.7762/cnr.2024.13.1.8